Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis-Reference-Cited by-同舟云学术

Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis

Published:2017-05-09 Issue:8 Volume:72 Page:2334-2341
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Müller Joachim¹,Aguado-Martínez Adriana¹,Ortega-Mora Luis-Miguel²,Moreno-Gonzalo Javier²,Ferre Ignacio²,Hulverson Matthew A.³,Choi Ryan³,McCloskey Molly C.³,Barrett Lynn K.³,Maly Dustin J.⁴,Ojo Kayode K.³,Van Voorhis Wes³,Hemphill Andrew¹

Affiliation:

1. Institute of Parasitology, Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Länggass-Strasse 122, CH-3012 Bern, Switzerland

2. SALUVET, Animal Health Department, Faculty of Veterinary Sciences, Complutense University of Madrid, Ciudad Universitaria s/n, 28040 Madrid, Spain

3. Center for Emerging and Reemerging Infectious Diseases (CERID), Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA

4. Department of Chemistry, University of Washington, Seattle, WA, USA

Funder

National Institutes of Health

Swiss National Science Foundation

U.S. Department of Agriculture

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/72/8/2334/24332280/dkx134.pdf

Reference51 articles.